Home/Filings/4/0001437749-13-009182
4//SEC Filing

Furiex Pharmaceuticals, Inc. 4

Accession 0001437749-13-009182

CIK 0001484478operating

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 9:24 PM ET

Size

14.0 KB

Accession

0001437749-13-009182

Insider Transaction Report

Form 4
Period: 2013-07-19
McIntyre Gail Frances
Senior Vice President-Research
Transactions
  • Sale

    Common Stock

    2013-07-19$40.00/sh10,581$423,24017,868 total
  • Tax Payment

    Common Stock

    2013-07-19$40.00/sh9,419$376,76028,449 total
  • Exercise/Conversion

    Stock Options (to buy)

    2013-07-19+20,00055,691 total
    Exercise: $9.11Exp: 2020-06-17Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-07-19$9.11/sh+20,000$182,20037,868 total
Holdings
  • Stock Options (to buy)

    Exercise: $15.00Exp: 2021-05-09Common Stock (26,000 underlying)
    26,000
  • Stock Options (to buy)

    Exercise: $13.16Exp: 2021-10-03Common Stock (37,944 underlying)
    37,944
  • Stock Options (to buy)

    Exercise: $17.80Exp: 2022-02-24Common Stock (10,368 underlying)
    10,368
Footnotes (5)
  • [F1]This sale was pursuant to a Rule 10b5-1 Sales Plan, which is intended to comply with Rule 10b5-1.
  • [F2]The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
  • [F3]The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
  • [F4]The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
  • [F5]The options were awarded on 2/24/2012 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.

Issuer

Furiex Pharmaceuticals, Inc.

CIK 0001484478

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001484478

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 9:24 PM ET
Size
14.0 KB